|1.||Okutan, Ozerk: 4 articles (04/2007 - 04/2004)|
|2.||Beskonakli, Etem: 4 articles (04/2007 - 04/2004)|
|3.||Kilinc, Kamer: 3 articles (04/2007 - 01/2005)|
|4.||Nahum, Amit: 2 articles (07/2014 - 05/2009)|
|5.||Marcus, Nufar: 2 articles (07/2014 - 05/2009)|
|6.||Levy, Yael: 2 articles (07/2014 - 05/2009)|
|7.||Wang, Haibo: 2 articles (01/2014 - 11/2013)|
|8.||Zhang, Daogong: 2 articles (01/2014 - 11/2013)|
|9.||Gok, Beril: 2 articles (04/2007 - 04/2007)|
|10.||Kaptanoglu, Erkan: 2 articles (01/2005 - 04/2004)|
09/01/2012 - "Intravenous administration of methylprednisolone sodium succinate 1,000 mg/day dramatically improved her pain as evaluated by the visual analog scale. "
01/01/2011 - "Her strength and pain quickly improved after hospitalization and treatment with intravenous solumedrol, pain control, and physiotherapy. "
11/01/2003 - "The aim of this study was to compare the effects of intravenous administration of 1.5 mg/kg and 3 mg/kg of methylprednisolone sodium succinate (MP) on pain, swelling, and trismus after third molar surgery. "
12/01/2009 - "He was given an injection of methylprednisolone sodium succinate; however his lower limb pain, fever and peripheral blood eosinophilia worsened. "
12/01/2009 - "Since a challenge test using an intravenous infusion of methylprednisolone sodium succinate worsened the lower limb pain, fever and peripheral blood eosinophilia, a drug allergy was diagnosed together with Churg-Strauss syndrome."
06/01/1978 - "Topical cardiac hypothermia: the effect of methylprednisolone sodium succinate."
05/01/1976 - "An established experimental model in which this lesion could be consistently produced in calves, was utilized to examine the protective role of hypothermia and/or Solumedrol infusion. "
05/01/1976 - "Solumedrol infusion and systemic hypothermia were not sufficiently effective in protecting the myocardium against 40 minutes of left coronary artery occlusion during total cardiopulmonary bypass. "
06/15/2015 - "To further investigate the effects of therapeutic hypothermia (TH), the present study compared autophagy and apoptosis after treatment with either therapeutic moderate systemic hypothermia or methylprednisolone sodium succinate (MP) in a rat model of acute spinal cord injury (SCI). "
02/01/1975 - "22 adult mongrel dogs were divided into 4 groups: 1) controls (fluid balanced after endotoxin injection); 2) steroid only administered (methylprednisolone sodium succinate (30 mg/kg, after endotoxin injection); 3) steroids and assisted circulation (normothermal); and 4) assisted circulation (hypothermia). "
01/01/2010 - "Treatment was initiated with intravenous pulse solumedrol, with improvement in vision and resolution of the patient's white-centered hemorrhages. "
08/01/1999 - "Gastric hemorrhage in dogs given high doses of methylprednisolone sodium succinate."
03/01/1988 - "In contrast, the administration of a single 30 mg/kg i.v. dose of methylprednisolone sodium succinate 30 min after the acute hemorrhage resulted in stabilization of caudate blood flow and vascular resistance and some restoration of those parameters toward prehemorrhage values. "
01/01/1981 - "In five of the thirteen dogs, 30 mg/kg of methylprednisolone sodium succinate were administered intravenously one hour after hemorrhage. "
08/01/1999 - "To determine whether healthy dogs given high doses of methylprednisolone sodium succinate (MPSS) develop gastrointestinal tract ulcers and hemorrhage. "
|4.||Spinal Cord Injuries (Spinal Cord Injury)
03/01/1995 - "A model simulating acute-compressive spinal cord trauma at the second lumbar spinal cord segment (100 g, 300 seconds) was used to evaluate the efficacy of a vehicle control, methylprednisolone sodium succinate (MPSS), and a 21-aminosteroid compound (U74389G). "
11/01/2009 - "Currently, methylprednisolone sodium succinate (MPSS) is the standard treatment following acute spinal cord injury (SCI) as a consequence of the results obtained from the National Acute Spinal Cord Injury Studies. "
05/01/2009 - "The use of methylprednisolone sodium succinate (MPSS) in the treatment of traumatic spinal cord injury was initially reported to enhance recovery in the National Acute Spinal Cord Injury Studies (NASCIS), 1990 and 1997. "
01/01/2008 - "Although the primary outcomes in these trials were laregely negative, a secondary analysis of the North American Spinal Cord Injury Study II demonstrated that when administered within 8 hours of injury, methylprednisolone sodium succinate was associated with modest clinical benefits, which need to be weighed against potential complications. "
01/01/2004 - "The publication of the first National Acute Spinal Cord Injury (NASCIS) trial in 1984 ushered in the era of pharmacological trials of therapies intended to improve neurologic outcome in acute SCI. Subsequent trials of methylprednisolone sodium succinate (MPSS) and GM-1 have added to the evidence basis that informs the current management practices for acute SCI. The last 50 years have seen a conceptual shift from the pessimism of the past to a cautious optimism that the meager prognosis for neurologic recovery in acute SCI will yield to the progress of medical science. "
12/01/1983 - "[Methylprednisolone sodium succinate in acute myocardial infarct]."
01/01/1977 - "The number of deaths were the same in both the groups, myocardial infarction and cardiac arrhythmias were definitely lower in the Solu-Medrol group. "
11/01/1980 - "In a double-blind randomized study, 30 mg/kg of methylprednisolone sodium succinate (MPN) or 15 mg/kg of mannitol placebo (PL) were infused in 28 patients after acute myocardial infarction. "
07/01/1984 - "The effect of methylprednisolone sodium succinate (MP) on release of myosin light chain II (LCII) from the myocardium was studied in experimental myocardial infarction (MI). "
01/01/1978 - "This laboratory and others have shown that methylprednisolone sodium succinate and betahistine hydrochloride can each reduce the size of experimental myocardial infarct in dogs at six hours. "
|2.||Methylprednisolone Hemisuccinate (A-MethaPred)
|3.||Etoposide (VP 16)
|9.||Antineutrophil Cytoplasmic Antibodies (ANCA)
|1.||Drug Therapy (Chemotherapy)
|2.||Cardiopulmonary Bypass (Heart-Lung Bypass)
|4.||Spinal Fusion (Spondylosyndesis)